Verified Document

Status Of World-Level Laboratory Biorisk Essay

For instance, in December 2009, the U.S. government published its "National Strategy for Countering Biological Threats," representing the basic framework for the U.S. response to emerging bioterrorism threats. In the State of the Union address in 2010, President Barack Obama mentioned the National Strategy as an approach that "will give us the capacity to respond faster and more effectively to bioterrorism or an infectious disease." The implementation and oversight of this initiative is the responsibility of the U.S. Department of State's Biosecurity Engagement Program (BEP). This agency is tasked with promoting the National Strategy through efforts targeted at improving biorisk management and infectious disease surveillance practices around the world. To this end, the BEP has strengthened its commitment to the African continent, including countries in North Africa, the Horn of Africa, as well as the South Africa. In addition, the BEP has launched programs in those regions that are characterized by the highest terrorism and infectious disease outbreak threats, with West Africa and the Congo Basin being preeminent among these regions (Jenkins, 2011). At the national level, the U.S. strategy for biorisk management is focused on a two-fold approach that uses indirect, preventative measures based on the goals of the Biological Weapons Convention (BWC), which are (a) collaboration with State Parties to improve the security of laboratories that work with dangerous pathogens and (b) to improve global disease surveillance (e.g., the ability to detect and rapidly contain outbreaks of infectious disease, whether they are natural, accidental, or deliberate in origin) (Tucker, 2010). According to Tucker (2010), the 23-page National Strategy for Countering Biological Threats document was distributed all of the members of the annual meeting of states-parties to the BWC in Geneva in December 2009. Whereas the Bush administration's biosecurity policies focused on mitigating the consequences of a biological attack through a major investment in threat assessment research, early-detection systems such as BioWatch, the development of medical countermeasures under Project BioShield in 2004, and other domestic preparedness measures, the Obama strategy places a far greater emphasis on prevention (Pupura, 2007). Noting the two-phase approach used for the Bioshield initiative, Mayer (2007) adds that, "The [Bioshield I and II] proposals offered a sweeping array of reforms to coordinate national biodefense efforts and stimulate private development of medical countermeasures for deadly biowarfare agents" (p. 1753).

Conclusion

Without aggressive action today, the same innovations in biotechnology that have taken place in recent years may become humankind's doom in the future. Today, there is a compelling need to develop...

This balance, though, is far less significant compared to the challenges in the future. The international security community today must respond to the rapid acceleration and movement of dual-use knowledge by the globalization-fueled quest to be more competitive and to replenish its drying drug development pipelines (Finlay, 2010). Moreover, as the industry develops additional dual-use technologies that are shared with nations that lack the capability or wherewithal to secure their biotechnological resources and facilities, there will be a concomitant increase in the potential for intentional or unintentional, anthropomorphic or natural, biological incidents. Clearly, there is a growing need for a timely and informed approach to biorisk management that conforms to the provisions of IHR 2005 and the Biological Weapons Convention. For this purpose, World Health Organization's Emerging and Dangerous Pathogens Laboratory Network offers a viable framework in which to provide the technical expertise that emerging nations need to help them secure their biological resources and facilities, but time is of the essence and there is no room for false starts (Finlay, 2010). Such timely responses will also require adequate contingency plans for the control of release of information and the potential for panic, rioting and looting among affected populations.
References

Biorisk reduction. (2011). World Health Organization. Retrieved from http://www.who.int / csr/bioriskreduction/en/.

Global alert and response. (2011). World Health Organization. Retrieved from http://www.

who.int/csr/bioriskreduction/laboratorynetwork/en/index.html.

Global Outbreak Alert and Response Network Fact Sheet. (2011). World Health Organization.

Retrieved from http://www.who.int/csr/outbreaknetwork/goarnenglish.pdf.

Global Outbreak Alert & Response Network. (2011). World Health Organization. Retrieved from http://www.who.int/csr/outbreaknetwork/en/.

Jenkins, B. (2011, January/February). Adapting to the times: the evolution of U.S. threat reduction programs. Arms Control Today, 41(1), 14-16.

Mayer, L. (2007). Immunity for immunizations: Tort liability, Biodefense, and Bioshield II.

Stanford Law Review, 59(6), 1753-1755.

Purpura, P.P. (2007). Terrorism and homeland security: An introduction with applications.

Boston: Butterworth-Heinemann.

Strengthening laboratory core capacity. (2011). World Health Organization. Retrieved from http://www.who.int/ihr/en/.

Sources used in this document:
References

Biorisk reduction. (2011). World Health Organization. Retrieved from http://www.who.int / csr/bioriskreduction/en/.

Global alert and response. (2011). World Health Organization. Retrieved from http://www.

who.int/csr/bioriskreduction/laboratorynetwork/en/index.html.

Global Outbreak Alert and Response Network Fact Sheet. (2011). World Health Organization.
Retrieved from http://www.who.int/csr/outbreaknetwork/goarnenglish.pdf" target="_blank" REL="NOFOLLOW" style="text-decoration: underline !important;">http://www.who.int/csr/outbreaknetwork/goarnenglish.pdf.
Global Outbreak Alert & Response Network. (2011). World Health Organization. Retrieved from http://www.who.int/csr/outbreaknetwork/en/.
Strengthening laboratory core capacity. (2011). World Health Organization. Retrieved from http://www.who.int/ihr/en/" target="_blank" REL="NOFOLLOW" style="text-decoration: underline !important;">http://www.who.int/ihr/en/.
Cite this Document:
Copy Bibliography Citation

Related Documents

Bioterrorism Case Study on Bioterrorism Create a
Words: 554 Length: 2 Document Type: Case Study

Bioterrorism Case Study on Bioterrorism Create a scenario of a hypothetical bioterrorist attack involving botulism or plague. Your scenario should include characteristics that are more indicative of an intentional outbreak than a natural outbreak. Yersinia pestis is the causative agent of plague, an enzootic vectorborne disease usually infecting rodents (rats) and fleas and humans can become infected after being bitten by fleas that have fed on infected rodents; in humans, the disease usually

Bioterrorism and Its Future Impact on Nursing
Words: 1681 Length: 5 Document Type: Term Paper

Bioterrorism and Future Impact in Nursing Biological warfare threat has spread across the globe from developed to developing, countries in the last few years. It causes alarm among the professionals such as journalist, academics, and policy analysts. Most important, it has caught the attention of policy makers and policy analysts to rethink the whole concept of bioterrorist (Sharyn Janes, 2008). Therefore, what is Bioterrorist? What is its future impact in nursing?

Bioterrorism Is "The Use, or Threatened Use,
Words: 1816 Length: 4 Document Type: Research Paper

Bioterrorism is "the use, or threatened use, of biological agents to promote or spread fear or intimidation upon an individual, a specific group, or the population as a whole for religious, political, ideological, financial, or personal purposes" (Arizona Department of Health Services, 2005). Bioterrorism is the weaponization of biological agents or material; as such, it poses a huge potential risk to the United States, given the relative affordability and accessibility

Bioterrorism Biological Weapon Can Be Defined As
Words: 810 Length: 2 Document Type: Essay

Bioterrorism Biological weapon can be defined as any kind of organism such as the bacteria, fungi or viruses, or any toxin (poisonous compounds that are produced by organisms) that can be used to kill the host or kill/injure human beings. There are varying acts of bioterrorism ranging from a hoax to actual use of these biological weapons or agents. Of late, a very significant number of countries are pursuing the ownership

Bioterrorism Has Been Noted As the Use
Words: 538 Length: 2 Document Type: Essay

Bioterrorism has been noted as the use of any kind of organism such as the bacteria, fungi or viruses, or any toxin (poisonous compounds that are produced by organisms) to eliminate the host. These elements are known to exist naturally within our environment. This then presents a legal loophole into who is supposed to posses these elements and what quantities would be termed as enough to be considered a weapon.

Bioterrorism Biological Weapons Can Significantly Change the
Words: 1425 Length: 5 Document Type: Research Paper

Bioterrorism Biological weapons can significantly change the battlefield. Today's leaders must always be on the watch for new threats that can arise in newly designed ways. The enemy is always planning to expose weaknesses in the defense. Biological weaponry is such a technology that can bring devastating effects and exploit weaknesses both tactically and strategically. The purpose of this essay is to examine the appeal of biological weapons to terrorist organizations.

Sign Up for Unlimited Study Help

Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.

Get Started Now